Why is Marsh & McLennan Companies filing an 8-K regarding the sale of Kroll?

MMC is filing this 8-K to formally report significant divestiture events, specifically the sale of Kroll Inc. and previously Kroll Laboratory Specialists (KLS). This filing provides updated financial information reflecting these changes, particularly the classification of these entities as discontinued operations.

What is the financial impact of selling Kroll and KLS on MMC?

The filing indicates that Kroll Inc. and KLS have been classified as discontinued operations. Investors should refer to the amended financial statements and MD&A attached to this 8-K (Exhibits 99.1, 99.2, 99.3) for a detailed understanding of the financial impact, including how these sales affect MMC's reported revenue, expenses, and profitability going forward.

Where can I find the updated financial information related to these sales?

The updated financial information is provided through amended sections of MMC's 2009 Annual Report on Form 10-K. Specifically, Exhibits 99.1, 99.2, and 99.3 contain the amended Item 6 (Selected Financial Data), Item 7 (Management's Discussion and Analysis), and Item 8 (Financial Statements and Supplementary Data), respectively.

Are there any other material events reported in this 8-K?

This 8-K primarily focuses on the divestitures of Kroll entities and the subsequent financial reporting adjustments. It also includes standard forward-looking statement disclosures and risk factors that are relevant to MMC's ongoing business operations.

MRSH/MMC 8-K SEC Disclosure

Summary

Marsh & McLennan Companies, Inc. (MMC) filed this Form 8-K on September 2, 2010, to report significant updates regarding the divestiture of its subsidiaries. The filing clarifies that Kroll Laboratory Specialists (KLS) was sold in the first quarter of 2010, and its operating results were deemed insignificant to be reclassified as discontinued operations at that time. However, the subsequent sale of Kroll Inc. to Altegrity, Inc. on August 3, 2010, led MMC to classify both KLS and Kroll Inc. as discontinued operations in its second-quarter 2010 reporting. To reflect these changes accurately, MMC has provided amended financial presentations from its 2009 Annual Report on Form 10-K. These amended sections include Selected Financial Data, Management's Discussion and Analysis (MD&A), and the Financial Statements and Supplementary Data. Investors should review these updated sections to understand the financial impact of these divestitures and how they affect the company's overall reported performance and segment information.

Key Highlights

1MMC completed the sale of Kroll Inc. to Altegrity, Inc. on August 3, 2010.
2Kroll Laboratory Specialists (KLS) was sold in the first quarter of 2010.
3Both KLS and Kroll Inc. have been classified as discontinued operations as of the second quarter of 2010.
4Amended financial data from MMC's 2009 Form 10-K (Selected Financial Data, MD&A, Financial Statements) are provided as exhibits to reflect these divestitures.
5The initial sale of KLS in Q1 2010 did not result in reclassification to discontinued operations due to insignificance at that time.
6The filing includes standard forward-looking statement disclaimers and risk factors relevant to MMC's operations.

MARSH & MCLENNAN COMPANIES, INC. 8-K Report, Corporate Update (Sep 2, 2010)

Summary

Key Highlights

Frequently Asked Questions